ARCHIVES

Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

New Treatment Approach To Treating Brain Tumor

April 26, 2002

DCPC Board Okays Core Grant Changes On Shared Resources

January 30, 1987

In Brief: Breast Cancer Diet Study Problems Resolved, Funding Resumed For Nutrition Coordinator

April 19, 1985

Amgen Replaces “Bundling” Contract With Three Separate Contracts For Growth Factors.

September 5, 2008

NCAB Agrees With NCI Recommendation To Drop PO1 Chartered Committees, Adopt Single Review

February 13, 1987

NCA Approves Major Revision In Program Project Guidelines; Smaller, Tightly Focused Grants Seen

May 27, 1983